Ryvu Therapeutics (RVU)
- Share price (7-session average)
- 15.78 PLN-2.76% w/w
- Market cap
- PLN 639.3M
- 52-week range
- 13.64 – 31.90 PLN
Prices as of October 2, 2026, delayed.
Last updated: Source: ESEF / ESPI / GPW
Price Chart
About Ryvu Therapeutics
Ryvu Therapeutics is a biotechnology company developing innovative small molecule drugs, primarily in oncology. The most advanced project is a CDK8/19 inhibitor in Phase II clinical trials.
This description was generated with the help of AI and may contain inaccuracies. Please verify important information from official sources.
Company Details
Data sourced from GPW and OpenFIGI. Updated periodically — verify with official sources.
News
No news for RVU.
Communities
Frequently asked questions
- How much does a Ryvu Therapeutics share cost?
- The 7-day average share price of Ryvu Therapeutics (RVU) on GPW is 15.78 PLN.
- On which exchange is Ryvu Therapeutics listed?
- Ryvu Therapeutics is listed on GPW under the ticker RVU, ISIN: PLSELVT00013.
- Is Ryvu Therapeutics stock being shorted?
- Per the KNF short-selling register (as of October 4, 2026), there are no disclosed net short positions in Ryvu Therapeutics. KNF discloses positions from 0.5% of share capital, so smaller ones are not visible.
Similar companies — Biotechnology
Explore the market
This information is provided for informational purposes only and does not constitute investment advice or a recommendation. Listings describe companies by the stated criteria and are not an inducement to buy or sell any financial instrument. Verify figures against official sources before making any investment decision.